glp 1 approved for cardiovascular disease 💉 GLP-1's have been FDA over 20 years. 🫀 They have been found to improve overall health and reduce the risk of cardiovascular disease. 🧬 Obesity is a complex The cardiovascular effects of GLP-1

Does habit persistence after stopping a GLP-1 medication matter for weight loss maintenance success and how does that compare to a published Wegovy trial

Presented for research literature review only Niedwied A et al

Sinai Hospital, Toronto, Canada summarize and elucidate evidence that glucagon-like peptide-1 (GLP-1) receptor agonists (RAs), initially developed for the treatment of type 2 diabetes and weight management, demonstrate a surprisingly broad range of clinical benefits

This product is for research purposes only

I combine a deep understanding of medical wellness with a passion for science-backed health solutions and future-focused care